1283510

Lundbeck Seattle BioPharmaceuticals, Inc. — FEI 3017128566

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bothell, WA (United States)

Additional Details

Sponsor, Contract Research Organization